Cargando…

ODP211 Impact of Race and Chronic Kidney Disease on the Correlation between HbA1c and Continuous Glucose Monitoring (CGM) Glycemic Measures

OBJECTIVE: To determine whether the correlation between hemoglobin A1c (HbA1c) and continuous glucose monitoring (CGM) derived glycemic measures differs by patient race and stage of chronic kidney disease (CKD). METHODS: Two hundred thirty patients with type 1 or type 2 diabetes and a minimum of 10...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaplan, Leah, Anwar, Kanwal, Pittas, Anastassios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627974/ http://dx.doi.org/10.1210/jendso/bvac150.663

Ejemplares similares

ODP237 Relation Between Long Term Glycemic Variability (LTGV) and HbA1c Time-In-Range in Diabetic Patients.
por: Delgado-Vazquez, Angel Jesus, et al.
Publicado: (2022)

ODP169 Challenges with use of HbA1C for Evaluation of Blood Glucose Control
por: Maletkovic, Jelena
Publicado: (2022)

SAT099 Should We Use HbA1c Or Continuous Glucose Monitoring (CGM) For Treatment Adjustment In Type 2 Diabetes Non-insulin Treated Patients?
por: Totomirova, Tzvetelina, et al.
Publicado: (2023)

ODP210 Impact of Continuous Glucose Monitoring (CGM) in the Intensive Care Units (ICUs): Accuracy, Reliability, Feasibility and Nurse Acceptance
por: del Rincon, Juan, et al.
Publicado: (2022)

SAT-126 The Relationship of Continuous Glucose Monitoring (CGM)-Derived Time-in-Range (TIR) to Hemoglobin A1c (HbA1c)
por: Vigersky, Robert, et al.
Publicado: (2019)

ODP163 Association of HbA1c and Comfort with Diabetes Self-Management Among Adolescents and Young Adults with Type 1 Diabetes
por: Onwukwe, Obichi, et al.
Publicado: (2022)

SAT142 Utilization Of Continuous Glucose Monitoring In Diagnosis And Management Of Insulinoma
por: Phan, Van, et al.
Publicado: (2023)

OR03-3 Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes
por: Khan, Shanzay, et al.
Publicado: (2022)

ODP232 Postoperative Glycemic Management of Children Undergoing Pancreatectomy with Islet Autotransplantation
por: Grimbly, Chelsey, et al.
Publicado: (2022)

SAT115 Diabetes In Pregnancy: Evaluating Access And Usage Of Continuous Glucose Monitors (CGM) In A Medicaid Population
por: Chilukuri, Pranaya, et al.
Publicado: (2023)

THU253 The Hemoglobin Wayne Variant And Association With Falsely Elevated HbA1c
por: Mulpuri, Neha, et al.
Publicado: (2023)

PSUN317 IL-3 is associated with HbA1c and Serum Lipids in African Americans
por: Wamble, Ezekial, et al.
Publicado: (2022)

LBODP063 The Benefits Of Using Cgm For Intravenous Insulin Therapy
por: Bublik, Evgeniya, et al.
Publicado: (2022)

LBSUN292 Learning Lesson From A Case of Fulminant Type 1 Diabetes Mellitus Shortly After Pembrolizumab Treatment
por: Phan, Van, et al.
Publicado: (2022)

THU322 Lower HbA1c Is Associated With Lower In-Hospital Mortality In Patients With COVID-19
por: Tsikala Vafea, Maria, et al.
Publicado: (2023)

SUN-146 Glucose Clearance (GLCL) Using Continuous Glucose Monitoring (CGM)
por: Melish, John
Publicado: (2019)

MON-625 Utility of Continuous Glucose Monitoring in Children with Type 1 Diabetes: Is HbA1c Enough?
por: Owens, Lindsey L, et al.
Publicado: (2020)

SAT134 CGM Use During Pregnancy Complicated By CF-Induced Diabetes
por: Mazori, Alon Y, et al.
Publicado: (2023)

SAT152 Retrospective Analysis Of HbA1c In Patients Diagnosed With Pancreatic Insulinoma Prior To- And After Surgical Excision
por: Lawless, Sarah Jean, et al.
Publicado: (2023)

PSUN229 Transitions of Care and Readmissions in Patients with Diabetes Receiving CGM at Hospital Discharge
por: Barnett, Anne, et al.
Publicado: (2022)

PSUN300 The sex-specific correlation of IL7, high HbA1c and liver damage markers in African Americans
por: Webb, Kenisha, et al.
Publicado: (2022)

ODP194 EPC (Epilepsia Partialis Continue)- as a presenting symptom of HHS (Hyperglycemic Hyperosmolar Syndrome)
por: Patel, Toral, et al.
Publicado: (2022)

PSUN189 Psychological Treatment for Diabetes Distress is Associated with Reduction in HbA1c, Emergency Department Presentations and Improvement in Psychological Health.
por: Calderwood, Clare, et al.
Publicado: (2022)

THU266 Lowered HbA1c In Individuals With Long-term Type 1 Diabetes Undergoing BCG Bladder Cancer Therapy
por: Dias, Hans, et al.
Publicado: (2023)

ODP226 MONITORING THE INCIDENCES OF ALLERGIC CONTACT DERMATITIS AND OTHER SKIN REACTIONS ASSOCIATED WITH CONTINUOUS GLUCOSE MONITORING SYSTEMS
por: Lightstone, Hodaya, et al.
Publicado: (2022)

ODP164 Asynchronous Diabetes Virtual Interventions, Support, & Empowerment (ADVISE) Program to Improve Glycemic Control in High-Risk Youth and Adults with Type 1 Diabetes
por: Alharthi, Sahar, et al.
Publicado: (2022)

ODP260 New Type of Autoimmune Diabetes
por: Kumar, Surina, et al.
Publicado: (2022)

ODP165 Atypical DKA? Think Cannabis!
por: Albashaireh, Arwa, et al.
Publicado: (2022)

THU288 An Analysis Of The Association Between Age, HbA1c, Central Corneal Thickness, And Lens Thickness Using Swept-source Optical Coherence Tomography
por: Borkhetaria, Rucha K, et al.
Publicado: (2023)

ODP201 Fyn regulates sarcopenia via autophagy
por: Yamada, Eijiro, et al.
Publicado: (2022)

ODP227 Nivolumab Induced Type 1 Diabetes
por: Lim, Jonea, et al.
Publicado: (2022)

ODP186 Difficulties in diagnosing MODY: clinical case
por: Volkova, Natalya, et al.
Publicado: (2022)

MON-153 Spurious High HbA1c: Do We Need to Review the Guidelines?
por: Eid, Hatem
Publicado: (2019)

MON-LB025 An Artificially Low HbA1c as a Result of Dapsone Therapy
por: George, Robert, et al.
Publicado: (2019)

Online Education Improves Knowledge and Confidence Related to CGM and the AGP
por: Larkin, Amy, et al.
Publicado: (2021)

OR03-1 Achievement of HbA1c <6.5% without weight gain and hypoglycemia in people with type 2 diabetes treated with tirzepatide across the phase 3 SURPASS program
por: Allen, Sheryl Elaine, et al.
Publicado: (2022)

ODP204 Hemochromatosis and endocrine dysfunctions – a case report
por: Carvalho, Davide, et al.
Publicado: (2022)

ODP182 Diabetes types and risk of severe COVID-19
por: Kazlauskaite, Rasa, et al.
Publicado: (2022)

ODP180 Diabetes Apps: Do They Help Our Patients?
por: Xia, Alexander, et al.
Publicado: (2022)

ODP214 INSULIN REQUIRING DIABETES MELLITUS(IRDM) and CAD
por: Singh, Santosh
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_osmc5m59dtpbv836msmso31cqi